Literature DB >> 19458543

Hyperphosphorylated tau in the occipital cortex in aged nondemented subjects.

Maria Pikkarainen1, Tarja Kauppinen, Irina Alafuzoff.   

Abstract

To determine the extent of neurodegeneration of the visual association cortex, we assessed hyperphosphorylated tau-immunoreactive (HPtau-IR) neurofibrillary tangles in Brodmann Areas 18/19 in nondemented and demented subjects. At least occasional HPtau-IR neurofibrillary tangles were seen in 24% of 59 nondemented subjects with ages at death ranging from 42 to 87 years. The incidence increased to 41% in the 32 nondemented subjects who had HPtau-IR pathology in the hippocampal region. Demented subjects with Braak Stages 0 to III and corticobasal degeneration, frontotemporal lobar degeneration with TAR DNA binding protein 43, vascular cognitive impairment, or dementia with Lewy bodies also had HPtau-IR pathology in Brodmann Areas 18/19. These results support the concept that the occipital association area may have enhanced vulnerability to neurodegeneration. Neuropathologic assessment of these areas is, therefore, recommended, particularly in subjects suspected or known to have had mild cognitive impairment. Occasional HPtau-IR lesions were also seen in the medial temporal gyrus. Thus, the question as to whether scattered HPtau-IR lesions in either temporal or occipital cortex indicate a neurodegenerative disease remains unresolved. Further systematic clinicopathologic studies are needed for an understanding of regional susceptibility to neurodegeneration and the significance of scattered HPtau-IR brain lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19458543     DOI: 10.1097/NEN.0b013e3181a6ee45

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  6 in total

1.  Four distinct trajectories of tau deposition identified in Alzheimer's disease.

Authors:  Jacob W Vogel; Alexandra L Young; Neil P Oxtoby; Ruben Smith; Rik Ossenkoppele; Olof T Strandberg; Renaud La Joie; Leon M Aksman; Michel J Grothe; Yasser Iturria-Medina; Michael J Pontecorvo; Michael D Devous; Gil D Rabinovici; Daniel C Alexander; Chul Hyoung Lyoo; Alan C Evans; Oskar Hansson
Journal:  Nat Med       Date:  2021-04-29       Impact factor: 53.440

2.  Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.

Authors:  Dietmar Rudolf Thal; Christine A F von Arnim; W Sue T Griffin; Robert E Mrak; Lauren Walker; Johannes Attems; Thomas Arzberger
Journal:  J Neural Transm (Vienna)       Date:  2015-01-04       Impact factor: 3.575

3.  Modification of γ-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's disease.

Authors:  Francesc X Guix; Tina Wahle; Kristel Vennekens; An Snellinx; Lucía Chávez-Gutiérrez; Gerard Ill-Raga; Eva Ramos-Fernandez; Cristina Guardia-Laguarta; Alberto Lleó; Muriel Arimon; Oksana Berezovska; Francisco J Muñoz; Carlos G Dotti; Bart De Strooper
Journal:  EMBO Mol Med       Date:  2012-05-02       Impact factor: 12.137

4.  Hyperphosphorylated tau in young and middle-aged subjects.

Authors:  Adila Elobeid; Hilkka Soininen; Irina Alafuzoff
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

5.  Regional Molecular Mapping of Primate Synapses during Normal Healthy Aging.

Authors:  Laura C Graham; Michael J Naldrett; Steven G Kohama; Colin Smith; Douglas J Lamont; Barry W McColl; Thomas H Gillingwater; Paul Skehel; Henryk F Urbanski; Thomas M Wishart
Journal:  Cell Rep       Date:  2019-04-23       Impact factor: 9.423

6.  Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia.

Authors:  Diego Sepulveda-Falla; Justin S Sanchez; Kenneth S Kosik; Francisco Lopera; Yakeel T Quiroz; Maria Camila Almeida; Daniela Boassa; Juliana Acosta-Uribe; Clara Vila-Castelar; Liliana Ramirez-Gomez; Ana Baena; David Aguillon; Nelson David Villalba-Moreno; Jessica Lisa Littau; Andres Villegas; Thomas G Beach; Charles L White; Mark Ellisman; Susanne Krasemann; Markus Glatzel; Keith A Johnson; Reisa A Sperling; Eric M Reiman; Joseph F Arboleda-Velasquez
Journal:  Acta Neuropathol       Date:  2022-07-15       Impact factor: 15.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.